USPTO serial 97042423
FLEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 23, 2024
- Examiner
- JANSON, ANDREW KYLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kelly P. McCarthy
Kelly P. McCarthy SIDEMAN & BANCROFT LLPONE EMBARCADERO CENTER #2200SAN FRANCISCO, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for conducting research for ultra-high dose radiotherapy, treatment planning and patient monitoring; Downloadable computer software for evaluating treatment results for radiotherapy; Downloadable computer software for research about treatment plans for radiotherapy; Downloadable computer software for managing patient medical and treatment information; Downloadable computer software for creating searchable databases of information and data for use with medical research | ACTIVE | — |
| 010 | Medical linear accelerators used in radiotherapy and computer software embedded therein for use in the field of radiotherapy, sold as a unit; Medical apparatus, namely, medical device for use in patient positioning and immobilization during radiotherapy treatment, patient imaging, and diagnosis using scanning devices; Medical apparatus for locating and targeting cancer volumes in a body for use in radiation treatments; Medical apparatus, namely, medical device for maintaining patient positioning between and during treatment, imaging, diagnosis and simulation treatment in the field of radiation therapy; Radiation beam collimation apparatus for conformal beam radiotherapy; all of the foregoing goods limited to the radiation oncology field; Medical charged particle accelerators used in radiotherapy and computer software embedded therein for use in the field of radiotherapy, sold as a unit; Medical radiation delivery devices, namely, radiation therapy device; Ultra-high dose rate radiotherapy medical apparatus used for diagnostic, therapeutic and radiographic purposes and computer software embedded therein, sold as a unit, for use in the fields of radiotherapy and radiosurgery; Medical charged particle accelerators used in radiotherapy and radiosurgery and computer software embedded therein, sold as a unit, for use in the fields of radiotherapy and radiosurgery; Medical imaging apparatus for ultra-high dose rate radiotherapy treatment planning; Medical apparatus in the nature of devices for positioning patients, immobilizing limbs, and controlling patient motion during ultra-high dose rate radiotherapy treatment | ACTIVE | — |
| 042 | Providing online non-downloadable software for researching medical information, patient data, and patient treatment information; Providing online non-downloadable software for research to assist patients and medical professionals in formulating medical diagnoses and developing, adapting and facilitating medical treatment plans; Providing online non-downloadable software for research regarding ultra-high dose oncology treatment and patient care data management and analytics; Providing online non-downloadable software for controlling radiotherapy medical apparatus for use with oncology treatment; Consulting services in the field of hosting computer software applications; Providing technical support services, namely, troubleshooting of computer hardware and software problems and providing solutions to the problems; Providing online non-downloadable software for management and analysis of ultra-high dose oncology treatment and patient care data; Providing online non-downloadable software for use with oncology treatment devices and for creating and facilitating ultra-high dose oncology treatment plans | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks owned by Varian Medical Systems, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named FLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 23, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 20, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 19, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 19, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 18, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 26, 2024 | IUAF | USE AMENDMENT FILED | — |
| Feb 26, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 22, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 27, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 27, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 7, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 25, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 25, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 25, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 25, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 28, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 28, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 28, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |